Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
New England ABA is a Massachusetts-based provider of applied behavior analysis therapy focused on children and adolescents with autism and related developmental conditions. The company delivers home- and community-based behavioral therapy services and has also participated in caregiver education and clinical support initiatives. Founded in 2015, it built a regional footprint in Massachusetts before being acquired in 2019 by The Stepping Stones Group. Following the acquisition, New England ABA continued operating under its existing name as a subsidiary. Its business is healthcare services rather than drug development, so it does not have a traditional biotech or pharmaceutical pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on New England ABA.